A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Please note that all translations are automatically generated. Click here for the English version.
2.5K Views
•
08:07 min
•
July 25th, 2022
DOI :
July 25th, 2022
•Rozdziały w tym wideo
0:05
Introduction
0:44
OMV-SC Preparation
3:02
RBD-ST Preparation
5:22
OMV-RBD Bioconjugation and Purification
6:39
Results: OMV-RBD Verification, Particle Size Distribution, and Visualization by TEM
7:42
Conclusion
Powiązane Filmy
12:09
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
42.7K Views
09:12
Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
6.9K Views
00:10
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
7.5K Views
08:40
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
58.9K Views
13:00
Engineering Antiviral Agents via Surface Plasmon Resonance
2.3K Views
10:06
Cellular Affinity of Particle-Stabilized Emulsion to Boost Antigen Internalization
1.8K Views
10:25
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
4.5K Views
05:15
Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay
3.5K Views
08:07
Profiling of Surface Protein Epitopes on Viral Particles by Multiplex Dual-Reporter Strategy
637 Views
06:39
High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells
3.0K Views
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone